A prospective observational study - understanding the burden of adverse drug reactions and their impact on symptoms at end of life in palliative care patients.

Flinders University0 个研究点目标入组 120 人开始时间: 2009年7月20日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•All patients consecutively referred to inpatient care at the Phase IV Palliative Care services for the first time and where the referral was either:
•1. for direct care with admission to the inpatient unit
•2. under the care of another medical specialty, and the service acted in a consultative arrangement, or
•3. where care was transferred from another medical specialty to the palliative care service for ongoing management.
•Between 1 September to 30 November 2009
•4. and who provide informed consent
•Patient Interview subset
•In addition to above
•1. Patients 18 years or older who give informed consent for interviews
•2.Australian modified Karnofsky Performance Status (AKPS) is =60 at the time of referral.

•1. Patient unable to give consent or for whom it was deemed inappropriate by the Palliative care team to participate in the interview.
•2. All patients transferred to other specialty unit within 24 hours of admission to the palliative care service.
•3. The patient, their family or the Palliative Care team can withdraw the patient at any time from the study.

发起方